Missouri patient survives double-lung transplant after innovative 48-hour bridge therapy removes infected lungs, offering new ...

Guillain-Barré Syndrome Presenting as Pseudo-Cerebellar Syndrome: A Case Report from a Resource-Limited Setting in Sub-Saharan Africa Guillain-Barré Syndrome (GBS) is the most frequent cause of acute ...

Zenocutuzumab--zbco, marketed as BIZENGRI (R), received Breakthrough Therapy Designation from the FDA in October 2025 and was granted accelerated approval in December 2024 for adults with advanced ...

Two years later, he's alive and well.

The 33-year-old patient arrived in dire straits, struck by acute respiratory distress syndrome (ARDS) triggered by the flu and worsened by bacterial pneumonia.

Adults hospitalized with an acute respiratory syncytial virus (RSV) infection faced an increased risk of cardiorespiratory events such as heart attack or stroke in the weeks afterward, according to a ...

A dispute has erupted between the family of a 42-year-old woman, Adunola Abiola, and a Lagos-based firm, Medical Ambulance ...

SynAct Pharma AB (publ) ("SynAct") (Nasdaq Stockholm: SYNACT), a clinical-stage biotechnological company focused on treating inflammation through resolution therapy, today announced that it has initia ...

LONDON, Feb 2 (Xinhua/APP): A groundbreaking case published this week in the journal Med reported the successful use of an external, artificial lung system to sustain a critically ill patient for 48 ...

NTLA stock faces binary risk: success could unlock multi-billion dollar markets, while setbacks may erase hundreds of ...

Angiotensin-converting enzyme (ACE) inhibitors were found to be independently associated with reducing all-cause mortality in ...